New Drug Approvals: August 2003

Date of Approval: August 12, 2003

Company: AstraZeneca

Treatment for Heterozygous Familial Hypercholesterolemia, Homozygous Familial Hypercholesterolemia, Hypertriglyceridemia

Crestor is a HMG-CoA reductase inhibitor approved as an adjunct to diet for the treatment of various lipid disorders including primary hypercholesterolemia, mixed dyslipidemia and isolated hypertriglyceridemia.

Date of Approval: August 19, 2003

Company: Bayer Corporation

Treatment for Erectile Dysfunction

Levitra is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5) indicated for the treatment of erectile dysfunction.

Date of Approval: August 27, 2003

Company: Bayer Corporation

Treatment for Primary Immunodeficiency Syndrome, Idiopathic (Immune) Thrombocytopenic Purpura, Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Gamunex (immune globulin intravenous (human)) is indicated for the treatment of primary humoral immunodeficiency, idiopathic thrombocytopenic purpura and chronic inflammatory demyelinating polyneuropathy (CIDP).

Company: GlaxoSmithKline

Treatment for Depression

Company: GlaxoSmithKline

Treatment for Depression